July 13, 2017 / 12:59 PM / 13 days ago

BRIEF-Halozyme announces initiation of clinical trial collaboration

1 Min Read

July 13 (Reuters) - Halozyme Therapeutics Inc:

* Initiation of clinical trial collaboration evaluating Halozyme's pegph20 in combination with anti-PDL1 immunotherapy

* Halozyme Therapeutics says combination will be tested in patients with previously treated metastatic pancreatic ductal adenocarcinoma

* Says ‍study is sponsored by and funded by Genentech​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below